The article describes and analyzes the psycho-emotional state indicators in patients with chronic alcoholic pancreatitis and atherosclerosis against the complex therapy background with the use of probiotics and melatonin. All patients were performed clinical-laboratory studies: lipid profile study (determination of total blood plasma cholesterol (LC), triglycerides (TG), high-density lipoprotein (HDL) and low-density lipoproteins (LDL), atherogenicity coefficient (CA)); feces research on dysbiosis. The alcoholic etiology of chronic pancreatitis was determined based on anamnestic data and using the AUDIT screening test. The dynamics of psycho-emotional disorders were studied using the HADS questionnaire and the “Emotional Condition Screening” technique. The emotional state screening was used to evaluate the subjects’ emotional state to identify critically (subclinical and pathological) abnormalities such as hypomania, somatoform, depressive, anxiety states and the tendency to abuse psychoactive substances. The intestinal dysbiosis degree was evaluated according to the classification of Kuvaeva IB, Ladodo KS. (1991).
The improvement in the colon microflora was observed in all patients who received Mucofalk and melatonin additionally to the complex treatment of chronic pancreatitis and atherosclerosis. Decrease in the subclinical and clinical manifestations of anxiety and depression according to the HADS questionnaire in these patients (subclinical and clinical manifestations of anxiety from 72.1% to 38.7%; subclinical and clinical manifestations of depression from 65.9% to 36.3 %) was observed after the treatment. According to the Emotional Condition Screening technique, there was a decrease in the level of pre-clinical and clinical emotional state disorders (hypomania and somatoform disorders; depressive and anxiety states; tendency to abuse psychoactive substances). At the same time, there was an increase in the frequency of emotional state critical indicators on the background of a decrease in the emotional disorders’ frequency in general, which we also regarded as some positive dynamics in such patients.
Samsonova NH, Zvenyhorodskaia LA, Cherkashova EA, Lazebnyk LB. Intestinal dysbiosis and atherogenic dyslipidemia. Eksperymentalnaia i klynycheskaia hastroenterolohyia. 2010; 03: 88-94.
Ciocan D, Rebours V, Voican CS, Wrzosek L, Puchois V, Cassard AM & Perlemuter G. Characterization of intestinal microbiota in alcoholic patients with and without alcoholic hepatitis or chronic alcoholic pancreatitis. Scientific REPORts. 2018; 8:4822: 1-11. DOI: https://doi.org/10.1038/s41598-018-23146-3 [PMid:29555983 PMCid:PMC5859299]
Macedo D, Chaves Filho AJM, de Sousa CNS, Quevedo J, Barichello T, Júnior HVN & de Lucena DF. Antidepressants, antimicrobials or both? Gut microbiota dysbiosis in depression and possible implications of the antimicrobial effects of antidepressant drugs for antidepressant effectiveness. Journal of affective disorders. 2017; 208: 22-32. DOI: https://doi.org/10.1016/j.jad.2016.09.012 [PMid:27744123]
Huang C, Chen J, Wang J, Zhou H, Lu Y, Lou L & Zeng Y. Dysbiosis of intestinal microbiota and decreased antimicrobial peptide level in Paneth cells during hypertriglyceridemia-related acute necrotizing pancreatitis in rats. Frontiers in microbiology. 2017; 8: 776. DOI: https://doi.org/10.3389/fmicb.2017.00776 [PMid:28522995 PMCid:PMC5415626]
Dinan TG, Cryan JF. Melancholic microbes: a link between gut microbiota and depression? Neurogastroenterology & Motility. 2013; 25(9): 713-719. DOI: https://doi.org/10.1111/nmo.12198 [PMid:23910373]
Serino M, Blasco-Baque V, Nicolas S & Burcelin R. Far from the eyes, close to the heart: dysbiosis of gut microbiota and cardiovascular consequences. Current cardiology reports. 2014; 16(11): 540. DOI: https://doi.org/10.1007/s11886-014-0540-1 [PMid:25303894 PMCid:PMC4194023]
Yin J, Liao SX, He Y, Wang S, Xia GH, Liu FT & Pan SY. Dysbiosis of gut microbiota with reduced trimethylamine‐N‐oxide level in patients with large‐artery atherosclerotic stroke or transient ischemic attack. Journal of the American Heart Association. 2015; 4(11): e002699. DOI: https://doi.org/10.1161/JAHA.115.002699
Khrystych TN. Znachenye mykrobyoty v patoheneze metabolycheskykh rasstroistv y razvytyy dysbyoza pry khronycheskom pankreatyte. Hastroenterolohyia Sankt-Peterburha. 2018, 3: 31-37.
Hristich TN, Hontsariuk DO. Comorbidity of chronic pancreatitis and metabolic syndrome: mechanisms of development. Herald of Pancreatic Club. 2019; 43(2): 15-19. DOI: https://doi.org/10.33149/vkp.2019.02.02
Kotsaba Yu, Babinets LS. Aktualnye aspekty prymenenyia probyotykov pry dysbyoze tolstoi kyshky. Semeinaia medytsyna. 2018; 4: 85-87. DOI: https://doi.org/10.30841/2307-5112.4.2018.161522
Foster JA, Rinaman L, Cryan JF. Stress & the gut-brain axis: regulation by the microbiome. Neurobiology of stress. 2017; 7: 124-136. DOI: https://doi.org/10.1016/j.ynstr.2017.03.001 [PMid:29276734 PMCid:PMC5736941]
Cryan JF, Dinan TG. Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nature reviews neuroscience. 2012; 13(10): 701-712. DOI: https://doi.org/10.1038/nrn3346 [PMid:22968153]
Matyukha OV, Nichik OV. Express evaluation of affective disorders: screening of emotional state. Ukrainskyi Visnyk Psykhonevrolohii. 2006; 4: 48-53.
Zaiets T, Boiko T, Dzyha S, Bakalets O. Increase of efficiency of acute of acute pancreatitis for the exclusion of stress factor, psycho-emotional load. ΛΌГOΣ. Mystetstvo naukovoyi dumky. 2019; 4: 64-66.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.